Market Snapshot: Global Sleep Apnea Management Market Will Reach $10.3Bn by 2022
The worldwide airway management accessories and sleep apnea management products market is expected to reach $10.3bn by 2022, a CAGR of 7.4%. This market is largely driven by the rising prevalence of age- and obesity-related respiratory disorders, the rising demand for at-home patient care and rapid growth of sleep apnea treatment device sales. The three major players are Philips Healthcare, ResMed and Drive DeVilbiss.
You may also be interested in...
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
Metabesity is a complex issue that will require a multi-disciplinary approach, concerted effort and clear regulatory pathway to achieve solutions.
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.